What is Gardasil?



Gardasil is a vaccine that is partially effective against some strains of HPV, some of which may cause cancer. The vaccine hit the US market before it had fully been tested and before long term consequences could be observed. Ask yourself these questions:

  • Do you want your young daughters FORCED to use a vaccine which has been inadequately tested?
  • Do you want your daughters to risk suffering the sometimes fatal side effects (THere have been 3,461 documented complaints of adverse reactions and up to 8 DEATHS)
  • Do you like the idea of a company like MERC being able to push its way thru the FDA approval process to beat its European competition to the marketplace?
    READ ON

    "Protective efficacy of this vaccine against different types of human papillomavirus was very low and the protection may be because of sub-clinical infection with human papillomavirus or antigenically related viruses. I feel safety is more important for any vaccine than efficacy."
    Pendru Raghunath,
    Senior Research Fellow
    Unesco-Mircen for Marine Biotechnology, College of Fisheries, Mangaloe-575002.


    "The Food & Drug Administration allowed Merck to use a potentially reactive aluminum containing placebo as a control for most trial participants, rather than a non-reactive saline solution placebo.[1] A reactive placebo can artificially increase the appearance of safety of an experimental drug or vaccine in a clinical trial. Gardasil contains 225 mcg of aluminum and, although aluminum adjuvants have been used in vaccines for decades, they were never tested for safety in clinical trials. Merck and the FDA did not disclose how much aluminum was in the placebo.[2]

    Animal and human studies have shown that aluminum can cause nerve cell death [3] and that vaccine aluminum adjuvants can allow aluminum to enter the brain, [4 5] as well as cause inflammation at the injection site leading to chronic joint and muscle pain and fatigue. [6 7] Nearly 90 percent of Gardasil recipients and 85 percent of aluminum placebo recipients followed-up for safety reported one or more adverse events within 15 days of vaccination, particularly at the injection site.[8] Pain and swelling at injection site occurred in approximately 83 percent of Gardasil and 73 percent of aluminum placebo recipients. About 60 percent of those who got Gardasil or the aluminum placebo had systemic adverse events including headache, fever, nausea, dizziness, vomiting, diarrhea, myalgia. [9 10] Gardasil recipients had more serious adverse events such as headache, gastroenteritis, appendicitis, pelvic inflammatory disease, asthma, bronchospasm and arthritis."
    Croft Woodruff
    Nutrition research and consultant
    Omira Health Centers Inc., #104 - 233 West 2nd, North Vancouver BC V7O1B4